Chronic idiopathic nausea of childhood

Katja Kovacic1, Adrian Miranda1, Gisela Chelimsky1

  • 1Center for Pediatric Neurogastroenterology, Division of Gastroenterology, Hepatology, and Nutrition, Medical College of Wisconsin, Milwaukee, WI.

Insights

Children with chronic idiopathic nausea, often adolescent females, experience severe daily symptoms and comorbid conditions like migraines. This contrasts with secondary nausea in functional abdominal pain, highlighting chronic nausea as a distinct, disabling condition.

Area of Science:

  • Pediatric Gastroenterology
  • Functional Gastrointestinal Disorders
  • Neurology

Background:

  • Chronic idiopathic nausea in children is poorly understood.
  • Distinguishing primary chronic nausea from secondary nausea in functional abdominal pain is crucial for diagnosis and management.

Purpose of the Study:

  • To compare the clinical characteristics of children with primary chronic idiopathic nausea to those with secondary nausea associated with functional abdominal pain.
  • To identify distinct features and comorbid conditions in each group.

Main Methods:

  • Retrospective chart review of 45 children with primary chronic nausea.
  • Comparison with prospectively collected data from 49 children with functional abdominal pain and comorbid nausea.
  • Analysis of symptom severity, demographics, and associated medical conditions.

Main Results:

  • The primary chronic nausea group comprised mostly adolescent Caucasian females with daily (88%) and constant (60%) nausea.
  • This group reported significantly higher rates of migraines (62%), familial migraines (71%), postural tachycardia syndrome (36%), and cyclic vomiting syndrome (27%).
  • Both groups experienced comorbid symptoms including anxiety, dizziness, fatigue, and sleep disturbances, with the chronic nausea cohort undergoing extensive negative medical workups.

Conclusions:

  • Primary chronic idiopathic nausea in children is characterized by severe, daily symptoms and a higher prevalence of migraine features and dysautonomia.
  • Chronic nausea represents a significant, disabling functional entity that warrants recognition as separate from functional abdominal pain.
  • Future research should investigate the interplay of comorbid conditions like migraine and dysautonomia in pediatric chronic nausea.
Abstract

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
820
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
4.5K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
1.1K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
1.1K
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
26
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
906